Personalizing antipsychotic treatment using genetics
Part of Mental health clinical trials.
This study looks at how a person's genes may affect how their body processes antipsychotic medications, with the goal of helping doctors choose the best medication and dose for each person. If you are changing or starting a new antipsychotic, this study might help you get more personalized treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have a diagnosis of schizophrenia.
- Your doctor should be changing or considering changing your antipsychotic medication because it's not working well enough, causing side effects, or you're not taking it as prescribed.
- You must be prescribed one of these medications: aripiprazole, olanzapine, paliperidone, quetiapine, risperidone, or amisulpride (as a pill or injection).
- You must not be currently taking clozapine.
- If you are of reproductive age, you must agree to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a genetic test (pharmacogenomics) can help doctors choose better medications for people with schizophrenia. If you've had side effects or your symptoms haven't improved with your current antipsychotic, this study may help find a treatment that works better for you.
This study compares a personalized medication plan based on your genes versus standard dosing for people with depression, anxiety, or psychosis. It may help your clinician choose a safer or more effective dose or medicine by using pharmacogenomics (gene-informed prescribing).
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
Hear when a new Patients With Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.